Bernstein SocGen on Oracle (ORCL): 'Next catalyst is FAM'
Tweet Send to a Friend
Bernstein SocGen Group analyst Mark Moerdler reiterated an Outperform rating and $325.00 price target on Oracle (NYSE: ORCL).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
